Clinical Trial Update: Effect of Adjunctive Metformin on Recurrence of Non-DM Colorectal Cancer Stage II High-risk/ III Colorectal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating whether adjunctive metformin reduces recurrence in non-diabetic patients with high-risk stage II or stage III colorectal can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Yonsei University | Conditions: Non-DM Stage II High-risk Colorectal Cancer, Non-DM Stage III Colorectal Cancer | Phase 3 | Status: UNKNOWN